Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn

Intensive Care Medicine

Volumn 23, Issue 12, 1997, Pages 1275-1278

  Soditt, V ^a   Aring, C ^a   Groneck, P ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Persistent pulmonary hypertension of the newborn; Premature neonate; Prostacyclin aerosol

Indexed keywords

PROSTACYCLIN; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; CASE REPORT; CLINICAL FEATURE; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURITY; PULMONARY HYPERTENSION; TIME; TISSUE OXYGENATION; VASODILATATION; VENTILATOR;

ADMINISTRATION, INHALATION; ANOXEMIA; EPOPROSTENOL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME; VASODILATOR AGENTS; VENTILATOR WEANING;

EID: 0031440703     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050498     Document Type: Article

References (22)

1. Walther FJ, Benders MJ, Leighton JO (1992) Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics 90: 899-904
2. Skinner JR, Boys RJ, Hunter S, Hey EN (1992) Pulmonary and systemic arterial pressure in hyaline membrane disease. Arch Dis Child 67: 366-373
3. Evans NJ, Archer LNJ (1991) Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. Arch Dis Child 66: 6-11
4. Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 818-819
5. Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340: 819-820
6. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB (1993) Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics 92: 606-609
7. Boynton BR, Hammond ND (1994) Pulmonary gas exchange: basic principles and the effects of mechanical ventilation. In: Boynton BR, Carlo WA, Jobe AH (eds) New therapies for neonatal respiratory failure. Cambridge University Press, Cambridge New York Melbourne, pp 127-128
8. Newth CJL, Clark AR (1989) In vitro performance of the small particle aerosol generator (SPAG-2). Pediatr Pulmonol 7: 183-188
9. Macdonald PD, Yu VYH (1992) Simultaneous measurement of preductal and postductal oxygen saturation by pulse oximetry in hyaline membrane disease. Arch Dis Child 67: 1166-1168
10. Golan A, Zalzstein E, Zmora E, Shinwell ES (1995) Pulmonary hypertension in respiratory distress syndrome. Pediatr Pulmonol 19: 221-225
11. Macrae DJ (1997) Drug therapy in persistent pulmonary hypertension of the newborn. Semin Neonatol 2: 49-58
12. D'Angeli MA, Goetzman BW (1992) Intratracheal administration of pulmonary vasodilator agents. Pediatr Pulmonol 14:85-90
13. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25: 329-340
14. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342: 961-962
15. Bindl L, Fahnenstich H, Peukert U (1994) Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Child 71: F214-F216
16. Zwissler B, Rank N, Jaenicke U, Schürle B, Welte M, Reichart B. Netz H. Messmer K, Peter K (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82: 1512-1516
17. Pappert D, Busch T, Gerlach H, Lewandowski K, Radermacher P, Rossaint R (1995) Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 82: 1507-1511
18. Ziegler JW, Ivy DD, Kinsella JP, Abman SH (1995) The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol 22: 387-403
19. Abman SH, Chatfield BA, Hall SL et al (1990) Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 259: H1921
20. Leffler CW, Hessler JR, Terragno NA (1980) Ventilation-induced release of prostaglandin-like material from fetal lungs. Am J Physiol 238: H282
21. Kerins DM, Murray R, Fitzgerald GA (1991) Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility. Prog Hemost Thromb, 10: 307-337
22. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 22: 426-433